Product Code: ETC035819 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Saudi Arabia anesthesia drug market is expected to witness a healthy growth during the forecast period, 2020-2026. This can be attributed to factors such as growing medical tourism, rising geriatric population, increasing prevalence of chronic diseases and rising demand for minimally invasive surgeries resulting in high utilization of anesthetic drugs. Moreover, technological advancements such as robotic surgery have further increased the use of anesthesia drugs. However, stringent regulatory framework and lack of skilled personnel may hamper the market growth over the forecast period.
The major drivers driving the growth of this market are growing medical tourism in Saudi Arabia due to its highly developed healthcare infrastructure along with easy accessibility to advanced treatments at low cost when compared with other countries. Additionally, rising geriatric population coupled with increasing prevalence of chronic diseases requiring surgical procedures is further propelling the demand for anesthetic drugs which in turn is boosting this market??s growth rate over the forecast period. Furthermore, technological advancements such as robotic surgery has resulted in increased complexity and accuracy leading to more usage of anesthetics drugs thereby contributing significantly towards this market??s development over years ahead.
However this industry faces certain challenges that hinder its overall progress; one major challenge being stringent regulations governing approval & marketing authorization related to manufacturing and distribution processes associated with these products making it difficult for companies operating within this space thus restraining their profits & sales volume significantly impacting negatively on global anesthesia drug markets development beyond a certain extent. In addition lack availability of properly trained personnel required for handling these devices appropriately often leads towards patient safety issues hindering product sale further adversely affecting industry`s expansion prospects across analyzed time frame considerably.
COVID-19 pandemic has had an adverse effect on the anaesthesia drugs market across Saudi Arabia due to temporary closure or suspension of elective surgery procedures and disruptions caused throughout value chain activities. However, with gradual easing down restrictions imposed by respective governments, the overall industry landscape is anticipated to witness advanced product launches along with several business strategies adopted by key players who will help them regain their lost positions over coming years post pandemic situation subsides completely.
Some major companies operating in this space include Baxter International Inc., Becton Dickinson & Company, Pfizer Inc., Fresenius SE & Co KGaA, Merck & Co., F Hoffmann La Roche Ltd., Novartis AG etc among others.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Anaesthesia Drug Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, 2020 & 2030F |
3.3 Saudi Arabia Anaesthesia Drug Market - Industry Life Cycle |
3.4 Saudi Arabia Anaesthesia Drug Market - Porter's Five Forces |
3.5 Saudi Arabia Anaesthesia Drug Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.6 Saudi Arabia Anaesthesia Drug Market Revenues & Volume Share, By Routes of Administration, 2020 & 2030F |
3.7 Saudi Arabia Anaesthesia Drug Market Revenues & Volume Share, By Applications, 2020 & 2030F |
4 Saudi Arabia Anaesthesia Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Saudi Arabia Anaesthesia Drug Market Trends |
6 Saudi Arabia Anaesthesia Drug Market, By Types |
6.1 Saudi Arabia Anaesthesia Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Type, 2020-2030F |
6.1.3 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By General , 2020-2030F |
6.1.4 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Local, 2020-2030F |
6.2 Saudi Arabia Anaesthesia Drug Market, By Routes of Administration |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Inhalation, 2020-2030F |
6.2.3 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Injection, 2020-2030F |
6.2.4 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Other , 2020-2030F |
6.3 Saudi Arabia Anaesthesia Drug Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By General Surgery, 2020-2030F |
6.3.3 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Plastic Surgery, 2020-2030F |
6.3.4 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Cosmetic Surgery, 2020-2030F |
6.3.5 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Dental Surgery, 2020-2030F |
6.3.6 Saudi Arabia Anaesthesia Drug Market Revenues & Volume, By Other, 2020-2030F |
7 Saudi Arabia Anaesthesia Drug Market Import-Export Trade Statistics |
7.1 Saudi Arabia Anaesthesia Drug Market Export to Major Countries |
7.2 Saudi Arabia Anaesthesia Drug Market Imports from Major Countries |
8 Saudi Arabia Anaesthesia Drug Market Key Performance Indicators |
9 Saudi Arabia Anaesthesia Drug Market - Opportunity Assessment |
9.1 Saudi Arabia Anaesthesia Drug Market Opportunity Assessment, By Type, 2020 & 2030F |
9.2 Saudi Arabia Anaesthesia Drug Market Opportunity Assessment, By Routes of Administration, 2020 & 2030F |
9.3 Saudi Arabia Anaesthesia Drug Market Opportunity Assessment, By Applications, 2020 & 2030F |
10 Saudi Arabia Anaesthesia Drug Market - Competitive Landscape |
10.1 Saudi Arabia Anaesthesia Drug Market Revenue Share, By Companies, 2023 |
10.2 Saudi Arabia Anaesthesia Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |